Screener
Phathom Pharmaceuticals, Inc. PHAT Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue, net | $74,274 | $39,503 | $132,575 | $68,023 |
| Cost of revenue | 15,096 | 5,038 | 27,091 | 8,762 |
| Gross profit | 59,178 | 34,465 | 105,484 | 59,261 |
| Operating expenses: | ||||
| Research and development | 7,813 | 9,076 | 15,585 | 18,260 |
| Selling, general and administrative | 55,330 | 85,313 | 109,341 | 179,787 |
| Total operating expenses | 63,143 | 94,389 | 124,926 | 198,047 |
| Loss from operations | (3,965) | (59,924) | (19,442) | (138,786) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s gross profit?
- Phathom Pharmaceuticals, Inc. (PHAT) reported gross profit of $59.18M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s gross profit changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s gross profit increased by 71.7% year-over-year, from $34.47M to $59.18M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Phathom Pharmaceuticals, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude